Is a serum vitamin B12 level of 304 pg/mL with elevated MCV borderline?

A serum B12 of 304 pg/mL in a 69-year-old man should be treated as an indeterminate result in the setting of macrocytosis, rather than as either proof of deficiency or reassurance that deficiency is absent.

Clinical interpretation

• A value of 304 pg/mL sits just above the often-cited 200–300 pg/mL borderline interval, but falls within broader indeterminate ranges used by guidance (approximately 150–399 pg/mL) for which confirmatory assessment may be appropriate.
• Persistently elevated MCV with normal folate is compatible with B12-related impaired DNA synthesis and megaloblastic change. However, MCV is diagnostically weak in isolation: reported sensitivity for low B12 was 17% in screened populations and 30% among anemic patients, with positive predictive values ranging from 0% to 55%.

Mechanistic and diagnostic clarification

• Total serum B12 includes haptocorrin-bound B12, much of which is not cell available, as well as transcobalamin-bound B12. This explains why total B12 can imperfectly reflect tissue-level availability.
• Methylmalonic acid (MMA) is the preferred functional follow-up test for an indeterminate B12 value; homocysteine can be supplementary but is less specific. Renal impairment and older age can raise MMA independently and must be considered in interpretation.

Alternative explanations for macrocytosis

• Macrocytosis warrants evaluation beyond B12. In one clinical series, alcohol accounted for 36.5% of cases, B12 deficiency 24.1%, and medication effects 12.9%. Hypothyroidism, liver disease, smoking, renal disease, and marrow disorders are additional considerations.

Bottom line

• A B12 of 304 pg/mL plus elevated MCV makes functional B12 inadequacy plausible, but not established. Clinical features, medication/alcohol review, thyroid and liver assessment, and appropriately interpreted MMA testing are central to clarification.